Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bockisch

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Heart and Vessels|July 19, 2005
Positron emission tomography/computed tomography improves diagnostics of inflammatory arteritisKnut Kröger, Gerald Antoch, Mathias Goyen, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2015
Impairment of lymphocyte function following yttrium-90 DOTATOC therapyVahé Barsegian, Christian Hueben, Stefan P Mueller, et al.
Investigative Radiology|November 25, 2003
Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imagingGerald Antoch, Walter Jentzen, Lutz S Freudenberg, et al.
Molecular Imaging and Biology|July 21, 2004
Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfallsAndreas Bockisch, Thomas Beyer, Gerald Antoch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2016
High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer MetastasesMarcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, et al.
EJNMMI Physics|October 27, 2015
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imagingWalter Jentzen, Marion Richter, James Nagarajah, et al.
Annals of Surgery|November 2, 2010
The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumorsAndrea Frilling, Georgios C Sotiropoulos, Arnold Radtke, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 23, 2012
Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administrationJens M Theysohn, Jörg F Schlaak, Stefan Müller, et al.
Nuclear Medicine Communications|July 11, 2006
Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancerWalter Jentzen, Elke Schneider, Lutz Freudenberg, et al.
Investigative Radiology|March 16, 2013
Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial resultsKarsten J Beiderwellen, Thorsten D Poeppel, Verena Hartung-Knemeyer, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Heart and Vessels|July 19, 2005
Positron emission tomography/computed tomography improves diagnostics of inflammatory arteritisKnut Kröger, Gerald Antoch, Mathias Goyen, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2015
Impairment of lymphocyte function following yttrium-90 DOTATOC therapyVahé Barsegian, Christian Hueben, Stefan P Mueller, et al.
Investigative Radiology|November 25, 2003
Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imagingGerald Antoch, Walter Jentzen, Lutz S Freudenberg, et al.
Molecular Imaging and Biology|July 21, 2004
Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfallsAndreas Bockisch, Thomas Beyer, Gerald Antoch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2016
High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer MetastasesMarcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, et al.
EJNMMI Physics|October 27, 2015
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imagingWalter Jentzen, Marion Richter, James Nagarajah, et al.
Annals of Surgery|November 2, 2010
The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumorsAndrea Frilling, Georgios C Sotiropoulos, Arnold Radtke, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 23, 2012
Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administrationJens M Theysohn, Jörg F Schlaak, Stefan Müller, et al.
Nuclear Medicine Communications|July 11, 2006
Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancerWalter Jentzen, Elke Schneider, Lutz Freudenberg, et al.
Investigative Radiology|March 16, 2013
Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial resultsKarsten J Beiderwellen, Thorsten D Poeppel, Verena Hartung-Knemeyer, et al.
Pageof 19